drugset
drugset / Trial / NCT04569695

A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants

NCT04569695 ↗

Phase 1 Completed 40 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to characterize the pharmacokinetics of single and multiple doses of JNJ-70033093 (BMS-986177) in healthy Chinese participants.

Timeline

Start
2021-03-08
Primary completion
2021-12-04
Completion
2021-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Milvexian Small molecule — Oral

Indications

No indication recorded.